N

Novel Therapeutics Pvt Ltd.

28 employees

Cellectar Biosciences is a pharmaceutical research company specializing in cancer drugs.

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
Early-Stage Chemotherapeutic Drug Conjugates
Hematologic Malignancies
Therapeutics
Targeted Delivery of Oncologic Payloads
PDC Cancer Therapeutics and Diagnostics

Date founded

2002

Funding rounds raised

Total raised

$103M

from 8 investors over 8 rounds

N

Novel Therapeutics Pvt Ltd. raised $103M on September 5, 2023

Investors: Second Line

N

Novel Therapeutics Pvt Ltd. raised $2M on September 22, 2022

Investors: National Cancer Institute

N

Novel Therapeutics Pvt Ltd. raised $2M on August 18, 2021

Investors: National Cancer Institute

N

Novel Therapeutics Pvt Ltd. raised $4M on January 1, 2014

Investors: Venture Investors and Wisconsin Investment Partners

N

Novel Therapeutics Pvt Ltd. raised $134K on January 1, 2012

Investors: Wisconsin Investment Partners

N

Novel Therapeutics Pvt Ltd. raised $13M on January 8, 2008

Investors: Venture Investors and Advantage Capital

FAQ